BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry. (Q40298317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tessa Holyoake

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

A Hamilton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

L Elrick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Myssina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Jørgensen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J V Melo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

1 reference

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1035-1039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

18 January 2020

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Roots of clinical resistance to STI-571 cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Punish the parent not the progeny.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404189

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2404189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16572205%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 January 2020

1007754357

0 references

1 reference